RAND » RAND Health » Centers » Bing Center for Health Economics

Bing Center for Health Economics

Improving health and the efficiency of health care service delivery are among today's most vexing public policy problems. RAND economists have a long and distinguished history of applying innovative research methods to such problems.

With the help of a generous donation from former RAND trustee Peter Bing, RAND created the Bing Center for Health Economics to continue and strengthen this tradition of innovative, high-profile research in health economics and health services research.

Featured Research

How Does Growth in Health Care Costs Affect the American Family? — Oct 3, 2011

In this October 2011 Congressional Briefing, Art Kellermann presents a breakdown of how U.S. health care cost growth directly affects the finances of a typical American family.

View the Video

News

Visiting Scholars Program Bids Farewell to Amitabh Chandra — Nov 30, 2011

Amitabh Chandra, a professor of public policy at Harvard University's Kennedy School of Government, was the latest Bing Center Visiting Scholar. Future Visiting Scholars include Doug Almond and Lena Edlund, from Columbia and Cornell; they will be visiting the Bing Center from March 15 to 30, 2012.

RAND Conference Focuses on Socioeconomic Growth and Development in Latin America — Nov 16, 2011

Labor issues, healthcare, education, social programs, and other factors affecting economic development in Latin America were the focus of a two-day conference in Santiago, Chile. RAND researchers joined university colleagues, industry experts, government leaders, and policymakers in discussing a range of critical topics.

Drug Cost Regulations Would Hurt Future Medical Innovation; Lower Copays a Better Option — Dec 16, 2008

Controlling prescription drug prices is one way to lower U.S. health costs, but it comes at a cost for future generations. While imposing European-style prescription drug price regulations in the United States would generate modest cost savings, it would impose a larger burden in the future by stifling medical innovation that can extend lives.

News Release

Focusing on Health Economics Research — Aug 8, 2007

Improving health and the efficiency of health care service delivery are among today's most vexing public policy problems. With the help of a generous donation from former RAND trustee Peter Bing, RAND created the Bing Center for Health Economics to address these issues with innovative, high-profile research.

View archived news and announcements

Recent Publications

Improving Value for Money in Funding HIV Services in Developing Countries

This brief summarizes options for improving value for money in HIV funding by using a case study that focuses on the two largest funders, the U.S. President’s Emergency Plan for AIDS Relief and the Global Fund, and antiretroviral therapy.

Research Brief

The PROMETHEUS Bundled Payment Experiment: Slow Start Shows Problems in Implementing New Payment Models

This project evaluated PROMETHEUS, a pilot project for a bundled payment alternative to fee for service. The pilot faced implementation challenges. Three years into the project, none of the pilot sites had executed contracts or made any bundled payments.

Abstract

International Comparisons in Health Economics: Evidence from Aging Studies

Provides an overview of the growing literature that uses micro-level data from multiple countries to investigate health outcomes, and their link to socioeconomic factors, at older ages.

Full Document

Value for Money in Donor HIV Funding

This report examines options for improving value for money in HIV funding by using a case study that focuses on the two largest funders, the U.S. President's Emergency Plan for AIDS Relief and the Global Fund, and antiretroviral therapy.

Full Document

Challenges to Value-Enhancing Innovation in Health Care Delivery: Commonalities and Contrasts with Innovation in Drugs and Devices

Discusses obstacles to steering innovation in health care toward activities that are worth their social costs and away from other innovative activities and considers drugs, devices, and delivery, with particular attention to delivery.